F Willgeroth
Impact in
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
- Oncology top 10%
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
- Cancer Diagnosis and Treatment
- Cancer Immunotherapy and Biomarkers
Papers in ⓘ
-
- Radiopharmaceutical Chemistry and Applications 2
- Radiomics and Machine Learning in Medical Imaging 2
- Oncology 6
- Cancer Cells and Metastasis 2
- HER2/EGFR in Cancer Research 2
- Co-authors
- Harald Sommer (3 shared papers)Klaus Pantel (2 shared papers)Stephan Braun (3 shared papers)F. Hepp (3 shared papers)J. De Waal (3 shared papers)Christina Kentenich (1 shared paper)Wolfgang Janni (1 shared paper)W Janni (2 shared papers)
- Journals
- Journal of Clinical Oncology (1 paper)RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren (1 paper)European Journal of Cancer (1 paper)Archives of Gynecology and Obstetrics (1 paper)Geburtshilfe und Frauenheilkunde (3 papers)
- Partner nations
- Germany
In The Last Decade
F Willgeroth
16 papers receiving 489 citations
Peers
Comparison fields: 5 of 67
- Cancer Research 209
- Oncology 376
- Pathology and Forensic Medicine 62
- Pulmonary and Respiratory Medicine 94
- Dermatology 25
Countries citing papers authored by F Willgeroth
This map shows the geographic impact of F Willgeroth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Willgeroth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Willgeroth more than expected).
Fields of papers citing papers by F Willgeroth
This network shows the impact of papers produced by F Willgeroth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Willgeroth. The network helps show where F Willgeroth may publish in the future.
Co-authors
The 25 scholars most cited alongside F Willgeroth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 315 | |
| 2 | Monoclonal antibody therapy with edrecolomab in breast cancer patients: monitoring of elimination of disseminated cytokeratin-positive tumor cells in bone marrow. | 1999 | 109 |
| 3 | 2007 | 32 | |
| 4 | 1982 | 8 | |
| 5 | 1972 | 8 | |
| 6 | 2007 | 7 | |
| 7 | [Microcalcifications on the mammaogram, surgical clarification and histologic findings. Concerning the problem of the diagnosis of occult carcinoma of the breast (author's transl)]. | 1976 | 5 |
| 8 | [Functional changes in the lower urinary tract after irradiation of cervix carcinoma]. | 1990 | 4 |
| 9 | 1991 | 3 | |
| 10 | 1979 | 3 | |
| 11 | 1988 | 2 | |
| 12 | Radiation exposure of the breast in film- and xero-mammography. | 1976 | 2 |
| 13 | 2005 | 1 | |
| 14 | 1977 | 1 | |
| 15 | 1999 | 1 | |
| 16 | [Experimental studies on the tumor uptake of mercury isotope labeled compounds]. | 1972 | 1 |
| 17 | 1983 | 1 |
About F Willgeroth
F Willgeroth is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Pathology and Forensic Medicine, Cancer Research and Surgery, having authored 17 papers that have together received 503 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (5 papers), Breast Lesions and Carcinomas (5 papers), Digital Radiography and Breast Imaging (2 papers), Cancer Cells and Metastasis (2 papers), HER2/EGFR in Cancer Research (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Breast Implant and Reconstruction (2 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). The work is most often cited by research in Cancer Research (209 citations), Oncology (376 citations), Pathology and Forensic Medicine (62 citations), Pulmonary and Respiratory Medicine (94 citations) and Dermatology (25 citations). F Willgeroth has collaborated with scholars based in Germany. Frequent co-authors include Harald Sommer, Klaus Pantel, Stephan Braun, F. Hepp, J. De Waal, Christina Kentenich, Wolfgang Janni, W Janni, G. Riethmüller and A. H. Tulusan. Their work appears in journals such as Journal of Clinical Oncology, RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, European Journal of Cancer, Archives of Gynecology and Obstetrics and Geburtshilfe und Frauenheilkunde.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.